Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N. Engl. J. Med 342:381-9, 2000.
Barr
C C
CC
D000418:Albumins / Q000378:metabolism; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006455:Hemoglobins, Abnormal / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D011379:Prognosis; D012160:Retina / Q000473:pathology
D000418:Albumins; D015415:Biomarkers; D001786:Blood Glucose; D006455:Hemoglobins, Abnormal; D007004:Hypoglycemic Agents; D007328:Insulin; C048900:hemoglobin, glycerated